BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34333382)

  • 1. SYNPO2 suppresses hypoxia-induced proliferation and migration of colorectal cancer cells by regulating YAP-KLF5 axis.
    OuYang C; Xie Y; Fu Q; Xu G
    Tissue Cell; 2021 Dec; 73():101598. PubMed ID: 34333382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer.
    Wang H; Zhang H; Sun Z; Chen W; Miao C
    Int J Biol Sci; 2021; 17(8):1953-1962. PubMed ID: 34131398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
    Li H; Rokavec M; Jiang L; Horst D; Hermeking H
    Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
    Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
    Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S; Sun G; Zhang D; Li Q; Qian H
    Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long intergenic noncoding RNA 00908 promotes proliferation and inhibits apoptosis of colorectal cancer cells by regulating KLF5 expression.
    Shan TD; Tian ZB; Li Q; Jiang YP; Liu FG; Sun XG; Han Y; Sun LJ; Chen L
    J Cell Physiol; 2021 Feb; 236(2):889-899. PubMed ID: 33020901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Inducible Exosomes Facilitate Liver-Tropic Premetastatic Niche in Colorectal Cancer.
    Sun H; Meng Q; Shi C; Yang H; Li X; Wu S; Familiari G; Relucenti M; Aschner M; Wang X; Chen R
    Hepatology; 2021 Nov; 74(5):2633-2651. PubMed ID: 34110633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.
    Ling HH; Kuo CC; Lin BX; Huang YH; Lin CW
    Exp Cell Res; 2017 Jan; 350(1):218-225. PubMed ID: 27914787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α.
    Zhang W; Yuan W; Song J; Wang S; Gu X
    Biochimie; 2018 Jan; 144():21-27. PubMed ID: 29017924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer.
    Shan TD; Xu JH; Yu T; Li JY; Zhao LN; Ouyang H; Luo S; Lu XJ; Huang CZ; Lan QS; Zhong W; Chen QK
    Oncotarget; 2016 Jan; 7(1):961-75. PubMed ID: 26510906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
    Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
    Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of HACE1 promotes colorectal cancer cell migration via upregulation of YAP1.
    Zhou Z; Zhang HS; Zhang ZG; Sun HL; Liu HY; Gou XM; Yu XY; Huang YH
    J Cell Physiol; 2019 Jun; 234(6):9663-9672. PubMed ID: 30362561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
    Xu M; Wang J; Li H; Zhang Z; Cheng Z
    Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
    Zhang J; Chu D; Kawamura T; Tanaka K; He S
    J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
    Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
    Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.